Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time?

Overview of attention for article published in Frontiers in immunology, April 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (58th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 1,492 followers.

RT @Federica_Autino: Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time? https://t.co/q9xrkk5nnU #immunology #gammdeltatcel…

Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time? by Claudia Giannotta https://t.co/z2M6s4yLji

RT @Federica_Autino: Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time? https://t.co/q9xrkk5nnU #immunology #gammdeltatcel…

Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time? https://t.co/q9xrkk5nnU #immunology #gammdeltatcells #science #immunotherapy

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.